About the role
Summary We are seeking a Scientist to join our growing In Vivo-Biology team. We are also open to relocating new colleagues to Oslo! In this role, you will play a key part in advancing our innovative pipeline of targeted radiotherapies designed to revolutionize cancer treatment. Are you a highly motivated scientist with a passion for in vivo oncology research? Do you thrive in a collaborative environment and enjoy tackling complex scientific challenges? If so, we encourage you to apply! \n Key
Responsibilities Design, execute, and interpret in vivo studies to evaluate the activity and therapeutic potential of radioligand candidates, and communicate findings through high-quality documentation and presentations. Partner with CROs, academic collaborators, and industry partners to deliver studies supporting the discovery, characterization, and optimization of radiotherapeutics. Collaborate effectively across multidisciplinary teams, engaging internal stakeholders to inform strategy and drive data-driven decision making. Provide scientific and operational leadership for in vivo components of project teams, ensuring seamless planning and execution. Develop, implement, and maintain laboratory protocols and safety procedures in alignment with regulatory, ethical, and radiation-protection standards. Remain current with scientific advancements, emerging technologies, and evolving best practices within the radiopharmaceutical and in vivo research fields. Contribute to the scientific community through authorship of peer-reviewed publications and by representing ARTBIO at conferences via oral or poster presentations.
Qualifications & Education PhD or equivalent degree in biomedical sciences, pharmacology, radiochemistry, medical physics, or a related discipline. Demonstrated hands-on experience with small-animal oncology models (mice and rats), supported by certified training in laboratory animal science (FELASA Category C, CAREiN, or equivalent). Experience in the evaluation and development of radiopharmaceuticals is highly desirable. Proven expertise in preclinical biodistribution and efficacy assessments using molecular imaging, ex vivo biodistribution, and related techniques. Working knowledge of dosimetry is an advantage. Prior experience managing external collaborations or CRO-based studies is beneficial. Ability to work independently while contributing effectively to collaborative, multidisciplinary teams. Exceptional attention to detail, strong interpersonal skills, and excellent organizational and communication capabilities. A creative, adaptable mindset and enthusiasm for contributing to a fast-paced, agile, small-company environment. \n
